Original Source(s)
Related Content
Retatrutide Shows 28% Weight Loss in Phase 3 Trial
Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.
May 21, 2026
-
2 min
Do Revisions in Rotator Cuff Repair Decline With GLP-1 Use?
Preoperative use was associated with fewer revisions and no increase in short-term complications among patients with obesity, although benefits appeared concentrated in select subgroups.
June 24, 2026
-
4 min